Relationship Between a Plant-Based Dietary Portfolio and Risk of Cardiovascular Disease: Findings From the Women's Health Initiative Prospective Cohort Study

Andrea J Glenn, Kenneth Lo, David J A Jenkins, Beatrice A Boucher, Anthony J Hanley, Cyril W C Kendall, JoAnn E Manson, Mara Z Vitolins, Linda G Snetselaar, Simin Liu, John L Sievenpiper, Andrea J Glenn, Kenneth Lo, David J A Jenkins, Beatrice A Boucher, Anthony J Hanley, Cyril W C Kendall, JoAnn E Manson, Mara Z Vitolins, Linda G Snetselaar, Simin Liu, John L Sievenpiper

Abstract

Background The plant-based Dietary Portfolio combines established cholesterol-lowering foods (plant protein, nuts, viscous fiber, and phytosterols), plus monounsaturated fat, and has been shown to improve low-density lipoprotein cholesterol and other cardiovascular disease (CVD) risk factors. No studies have evaluated the relation of the Dietary Portfolio with incident CVD events. Methods and Results We followed 123 330 postmenopausal women initially free of CVD in the Women's Health Initiative from 1993 through 2017. We used Cox proportional-hazard models to estimate adjusted hazard ratios (HRs) and 95% CI of the association of adherence to a Portfolio Diet score with CVD outcomes. Primary outcomes were total CVD, coronary heart disease, and stroke. Secondary outcomes were heart failure and atrial fibrillation. Over a mean follow-up of 15.3 years, 13 365 total CVD, 5640 coronary heart disease, 4440 strokes, 1907 heart failure, and 929 atrial fibrillation events occurred. After multiple adjustments, adherence to the Portfolio Diet score was associated with lower risk of total CVD (HR, 0.89; 95% CI, 0.83-0.94), coronary heart disease (HR, 0.86; 95% CI, 0.78-0.95), and heart failure (HR, 0.83; 95% CI, 0.71-0.99), comparing the highest to lowest quartile of adherence. There was no association with stroke (HR, 0.97; 95% CI, 0.87-1.08) or atrial fibrillation (HR, 1.10; 95% CI, 0.87-1.38). These results remained statistically significant after several sensitivity analyses. Conclusions In this prospective cohort of postmenopausal women in the United States, higher adherence to the Portfolio Diet was associated with a reduction in incident cardiovascular and coronary events, as well as heart failure. These findings warrant further investigation in other populations.

Keywords: cardiovascular disease; dietary patterns; dietary portfolio; plant‐based; prospective cohort study.

Conflict of interest statement

A.J.G. received funding from the Nora Martin Fellowship in Nutritional Sciences, Banting & Best Diabetes Centre Tamarack Graduate Award in Diabetes Research, the Peterborough K.M. Hunter Charitable Foundation Graduate Award, and the Ontario Graduate Scholarship. She has received consulting fees from Solo GI Nutrition and has received an honorarium from the Soy Nutrition Institute. D.J.A.J. has received research grants from Saskatchewan & Alberta Pulse Growers Associations, the Agricultural Bioproducts Innovation Program through the Pulse Research Network, the Advanced Foods and Material Network, Loblaw Companies Ltd., Unilever Canada and Netherlands, Barilla, the Almond Board of California, Agriculture and Agri‐food Canada, Pulse Canada, Kellogg's Company, Canada, Quaker Oats, Canada, Procter & Gamble Technical Centre Ltd., Bayer Consumer Care, Springfield, NJ, Pepsi/Quaker, International Nut & Dried Fruit Council (INC), Soy Foods Association of North America, the Coca‐Cola Company (investigator initiated, unrestricted grant), Solae, Haine Celestial, the Sanitarium Company, Orafti, the International Tree Nut Council Nutrition Research and Education Foundation, the Peanut Institute, Soy Nutrition Institute (SNI), the Canola and Flax Councils of Canada, the Calorie Control Council, the Canadian Institutes of Health Research (CIHR), the Canada Foundation for Innovation (CFI)and the Ontario Research Fund (ORF). He has received in‐kind supplies for trials as a research support from the Almond board of California, Walnut Council of California, the Peanut Institute, Barilla, Unilever, Unico, Primo, Loblaw Companies, Quaker (Pepsico), Pristine Gourmet, Bunge Limited, Kellogg Canada, WhiteWave Foods. He has been on the speaker's panel, served on the scientific advisory board and/or received travel support and/or honoraria from 2020 China Glycemic Index (GI) International Conference, Atlantic Pain Conference, Academy of Life Long Learning, the Almond Board of California, Canadian Agriculture Policy Institute, Loblaw Companies Ltd, the Griffin Hospital (for the development of the NuVal scoring system), the Coca‐Cola Company, Epicure, Danone, Diet Quality Photo Navigation (DQPN), Better Therapeutics (FareWell), Verywell, True Health Initiative (THI), Heali AI Corp, Institute of Food Technologists (IFT), Soy Nutrition Institute (SNI), Herbalife Nutrition Institute (HNI), Saskatchewan & Alberta Pulse Growers Associations, Sanitarium Company, Orafti, the International Tree Nut Council Nutrition Research and Education Foundation, the Peanut Institute, Herbalife International, Pacific Health Laboratories, Nutritional Fundamentals for Health (NFH), Barilla, Metagenics, Bayer Consumer Care, Unilever Canada and Netherlands, Solae, Kellogg, Quaker Oats, Procter & Gamble, Abbott Laboratories, Dean Foods, the California Strawberry Commission, Haine Celestial, PepsiCo, the Alpro Foundation, Pioneer Hi‐Bred International, DuPont Nutrition and Health, Spherix Consulting and WhiteWave Foods, the Advanced Foods and Material Network, the Canola and Flax Councils of Canada, Agri‐Culture and Agri‐Food Canada, the Canadian Agri‐Food Policy Institute, Pulse Canada, the Soy Foods Association of North America, the Nutrition Foundation of Italy (NFI), Nutra‐Source Diagnostics, the McDougall Program, the Toronto Knowledge Translation Group (St. Michael's Hospital), the Canadian College of Naturopathic Medicine, The Hospital for Sick Children, the Canadian Nutrition Society (CNS), the American Society of Nutrition (ASN), Arizona State University, Paolo Sorbini Foundation and the Institute of Nutrition, Metabolism and Diabetes. He received an honorarium from the United States Department of Agriculture to present the 2013 W.O. Atwater Memorial Lecture. He received the 2013 Award for Excellence in Research from the International Nut and Dried Fruit Council. He received funding and travel support from the Canadian Society of Endocrinology and Metabolism to produce mini cases for the Canadian Diabetes Association (CDA). He is a member of the International Carbohydrate Quality Consortium (ICQC). His wife, Alexandra L Jenkins, is a director and partner of INQUIS Clinical Research for the Food Industry, his 2 daughters, Wendy Jenkins and Amy Jenkins, have published a vegetarian book that promotes the use of the foods described here, The Portfolio Diet for Cardiovascular Risk Reduction (Academic Press/Elsevier 2020 ISBN:978‐0‐12‐810510‐8)and his sister, Caroline Brydson, received funding through a grant from the St. Michael's Hospital Foundation to develop a cookbook for one of his studies. A.J.H. received independent investigator‐initiated research funding from Dairy Farmers of Canada. C.W.C.K. has received research support from the Advanced Foods and Materials Network, Agricultural Bioproducts Innovation Program through the Pulse Research Network, Agriculture and Agri‐Food Canada, Almond Board of California, Barilla, Calorie Control Council, Canadian Institutes of Health Research, Canola Council of Canada, The International Tree Nut Council Nutrition Research & Education Foundation, Kellogg, Loblaw Companies Ltd., Pulse Canada, Saskatchewan Pulse Growers, and Unilever. He has received consultant fees from American Pistachio Growers; speaker fees from Tate & Lyle and The WhiteWave Foods Company; and travel funding from Sabra Dipping Company, Tate & Lyle, International Tree Nut Council Research & Education Foundation, California Walnut Commission, Sun‐Maid, The Peanut Institute, General Mills, Oldways Foundation and International Nut and Dried Fruit Council Foundation. He is on the Clinical Practice Guidelines Expert Committee for Nutrition Therapy of the European Association for the Study of Diabetes. He is a member of the International Carbohydrate Quality Consortium, Secretary of the Diabetes and Nutrition Study Group of the European Association for the Study of Diabetes, and a director of the Toronto 3D Knowledge Synthesis and Clinical Trials foundation. J.L.S. has received research support from the Canadian Foundation for Innovation, Ontario Research Fund, Province of Ontario Ministry of Research and Innovation and Science, Canadian Institutes of health Research (CIHR), Diabetes Canada, PSI Foundation, Banting and Best Diabetes Centre (BBDC), American Society for Nutrition (ASN), INC International Nut and Dried Fruit Council Foundation, National Dried Fruit Trade Association, National Honey Board (the U.S. Department of Agriculture [USDA] honey “Checkoff” program), International Life Sciences Institute (ILSI), Pulse Canada, Quaker, The United Soybean Board (the USDA soy “Checkoff” program), The Tate and Lyle Nutritional Research Fund at the University of Toronto, The Glycemic Control and Cardiovascular Disease in Type 2 Diabetes Fund at the University of Toronto (a fund established by the Alberta Pulse Growers), and The Nutrition Trialists Fund at the University of Toronto (a fund established by an inaugural donation from the Calorie Control Council). He has received in‐kind food donations to support a randomized controlled trial from the Almond Board of California, California Walnut Commission, Peanut Institute, Barilla, Unilever/Upfield, Unico/Primo, Loblaw Companies, Quaker, Kellogg Canada, WhiteWave Foods/Danone, and Nutrartis. He has received travel support, speaker fees and/or honoraria from Diabetes Canada, Dairy Farmers of Canada, FoodMinds LLC, International Sweeteners Association, Nestlé, Pulse Canada, Canadian Society for Endocrinology and Metabolism (CSEM), GI Foundation, Abbott, General Mills, Biofortis, ASN, Northern Ontario School of Medicine, INC Nutrition Research & Education Foundation, European Food Safety Authority (EFSA), Comité Européen des Fabricants de Sucre (CEFS), Nutrition Communications, International Food Information Council (IFIC), Calorie Control Council, and Physicians Committee for Responsible Medicine. He has or has had ad hoc consulting arrangements with Perkins Coie LLP, Tate & Lyle, Wirtschaftliche Vereinigung Zucker e.V., Danone, and Inquis Clinical Research. He is a member of the European Fruit Juice Association Scientific Expert Panel and Soy Nutrition Institute (SNI) Scientific Advisory Committee. He is on the Clinical Practice Guidelines Expert Committees of Diabetes Canada, European Association for the study of Diabetes (EASD), Canadian Cardiovascular Society (CCS), and Obesity Canada/Canadian Association of Bariatric Physicians and Surgeons. He serves or has served as an unpaid scientific advisor for the Food, Nutrition, and Safety Program (FNSP) and the Technical Committee on Carbohydrates of ILSI North America. He is a member of the International Carbohydrate Quality Consortium (ICQC), Executive Board Member of the Diabetes and Nutrition Study Group (DNSG) of the EASD, and Director of the Toronto 3D Knowledge Synthesis and Clinical Trials foundation. His wife is an employee of AB InBev. There are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1. Flow chart for study sample,…
Figure 1. Flow chart for study sample, WHI (Women's Health Initiative) cohort, 1993 to 2017.
Figure 2. Summary of findings of incident…
Figure 2. Summary of findings of incident cardiovascular disease, coronary heart disease, stroke, heart failure, and atrial fibrillation comparing low to high adherence to the Portfolio Diet.
Hazard ratios (HRs) and for comparing participants in Q1 (low adherence [reference category]) to Q4 (high adherence) of the Portfolio Diet with CVD outcomes in the Women's Health Initiative (Clinical Trials+Observational Study). Multivariate‐adjusted models were adjusted for the following: age, region, smoking, clinical trial study arm, ethnicity, education, marital status, hysterectomy history, body mass index, physical activity, alcohol intake, energy intake, cancer status, hypertension status, diabetes mellitus status, sodium intake, family history of CVD, family history of diabetes mellitus, hormone therapy use, and cholesterol‐lowering medication use. P trend was determined by assigning a median value to each quartile. Horizontal lines represent 95% CIs. CHD indicates coronary heart disease; and CVD, cardiovascular disease.

References

    1. Jenkins DJA, Kendall CWC, Faulkner D, Vidgen E, Trautwein EA, Parker TL, Marchie A, Koumbridis G, Lapsley KG, Josse RG, et al. A dietary portfolio approach to cholesterol reduction: combined effects of plant sterols, vegetable proteins, and viscous fibers in hypercholesterolemia. Metabolism. 2002;51:1596–1604. DOI: 10.1053/meta.2002.35578.
    1. Jenkins DJA, Kendall CWC, Marchie A, Faulkner D, Vidgen E, Lapsley KG, Trautwein EA, Parker TL, Josse RG, Leiter LA, et al. The effect of combining plant sterols, soy protein, viscous fibers, and almonds in treating hypercholesterolemia. Metabolism. 2003;52:1478–1483. DOI: 10.1016/S0026-0495(03)00260-9.
    1. Jenkins DJ, Kendall CW, Marchie A, Faulkner DA, Wong JM, de Souza R , Emam A, Parker TL, Vidgen E, Lapsley KG, et al. Effects of a dietary portfolio of cholesterol‐lowering foods vs lovastatin on serum lipids and c‐reactive protein. JAMA. 2003;290:502–510. DOI: 10.1001/jama.290.4.502.
    1. Jenkins DJA, Kendall CWC, Faulkner DA, Nguyen T, Kemp T, Marchie A, Wong JMW, de Souza R , Emam A, Vidgen E, et al. Assessment of the longer‐term effects of a dietary portfolio of cholesterol‐lowering foods in hypercholesterolemia. Am J Clin Nutr. 2006;83:582–591. DOI: 10.1093/ajcn.83.3.582.
    1. Jenkins DJA, Jones PJH, Lamarche B, Kendall CWC, Faulkner D, Cermakova L, Gigleux I, Ramprasath V, de Souza R , Ireland C, et al. Effect of a dietary portfolio of cholesterol‐lowering foods given at 2 levels of intensity of dietary advice on serum lipids in hyperlipidemia: a randomized controlled trial. JAMA. 2011;306:831–839. DOI: 10.1001/jama.2011.1202.
    1. Jenkins DJ, Chiavaroli L, Wong JM, Kendall C, Lewis GF, Vidgen E, Connelly PW, Leiter LA, Josse RG, Lamarche B. Adding monounsaturated fatty acids to a dietary portfolio of cholesterol‐lowering foods in hypercholesterolemia. CMAJ. 2010;182:1961–1967. DOI: 10.1503/cmaj.092128.
    1. Expert Panel on Detection E, Treatment of High Blood Cholesterol in A . Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:2486–2497. DOI: 10.1001/jama.285.19.2486.
    1. Chiavaroli L, Nishi SK, Khan TA, Braunstein CR, Glenn AJ, Mejia SB, Rahelić D, Kahleová H, Salas‐Salvadó J, Jenkins DJA, et al. Portfolio dietary pattern and cardiovascular disease: a systematic review and meta‐analysis of controlled trials. Prog Cardiovasc Dis. 2018;61:43–53. DOI: 10.1016/j.pcad.2018.05.004.
    1. Anderson TJ, Grégoire J, Pearson GJ, Barry AR, Couture P, Dawes M, Francis GA, Genest J Jr, Grover S, Gupta M, et al. 2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol. 2016;32:1263–1282. DOI: 10.1016/j.cjca.2016.07.510.
    1. Diabetes Canada Clinical Practice Guidelines Expert C , Sievenpiper JL, Chan CB, Dworatzek PD, Freeze C, Williams SL. Nutrition therapy. Can J Diabetes. 2018;42(suppl 1):S64–S79. DOI: 10.1016/j.jcjd.2017.10.009.
    1. Stroes ES, Thompson PD, Corsini A, Vladutiu GD, Raal FJ, Ray KK, Roden M, Stein E, Tokgözoğlu L, Nordestgaard BG, et al.; European Atherosclerosis Society Consensus P . Statin‐associated muscle symptoms: impact on statin therapy‐European Atherosclerosis Society consensus panel statement on assessment, aetiology and management. Eur Heart J. 2015;36:1012–1022. DOI: 10.1093/eurheartj/ehv043.
    1. Heart U.K . The cholesterol charity: portfolio diet. 2014.
    1. Viguiliouk E, Glenn AJ, Nishi SK, Chiavaroli L, Seider M, Khan T, Bonaccio M, Iacoviello L, Mejia SB, Jenkins DJA, et al. Associations between dietary pulses alone or with other legumes and cardiometabolic disease outcomes: an umbrella review and updated systematic review and meta‐analysis of prospective cohort studies. Adv Nutr. 2019;10:S308–S319. DOI: 10.1093/advances/nmz113.
    1. Veronese N, Solmi M, Caruso MG, Giannelli G, Osella AR, Evangelou E, Maggi S, Fontana L, Stubbs B, Tzoulaki I. Dietary fiber and health outcomes: an umbrella review of systematic reviews and meta‐analyses. Am J Clin Nutr. 2018;107:436–444. DOI: 10.1093/ajcn/nqx082.
    1. Mayhew AJ, de Souza RJ , Meyre D, Anand SS, Mente A. A systematic review and meta‐analysis of nut consumption and incident risk of cvd and all‐cause mortality. Br J Nutr. 2016;115:212–225. DOI: 10.1017/S0007114515004316.
    1. Schwingshackl L, Hoffmann G. Monounsaturated fatty acids, olive oil and health status: a systematic review and meta‐analysis of cohort studies. Lipids Health Dis. 2014;13:154. DOI: 10.1186/1476-511X-13-154.
    1. Zeraatkar D, Han MA, Guyatt GH, Vernooij RWM, El Dib R, Cheung K, Milio K, Zworth M, Bartoszko JJ, Valli C, et al. Red and processed meat consumption and risk for all‐cause mortality and cardiometabolic outcomes: a systematic review and meta‐analysis of cohort studies. Ann Intern Med. 2019;171:703–710. DOI: 10.7326/M19-0655.
    1. Estruch R, Ros E, Salas‐Salvadó J, Covas M‐I, Corella D, Arós F, Gómez‐Gracia E, Ruiz‐Gutiérrez V, Fiol M, Lapetra J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra‐virgin olive oil or nuts. N Engl J Med. 2018;378:e34. DOI: 10.1056/NEJMoa1800389.
    1. Prentice RL, Furberg C, Johnson S, Henderson M, Cummings S, Manson J, Freedman L, Oberman A, Kuller L, Anderson G. Design of the whi clinical trial and observational study. Control Clin Trials. 1998;19:61–109.
    1. Hays J, Hunt JR, Hubbell FA, Anderson GL, Limacher M, Allen C, Rossouw JE. The Women's Health Initiative recruitment methods and results. Ann Epidemiol. 2003;13:S18–S77. DOI: 10.1016/S1047-2797(03)00042-5.
    1. Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M. The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol. 2003;13:S107–S121. DOI: 10.1016/S1047-2797(03)00047-4.
    1. Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs‐Collins T. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol. 1999;9:178–187. DOI: 10.1016/S1047-2797(98)00055-6.
    1. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A data‐based approach to diet questionnaire design and testing. Am J Epidemiol. 1986;124:453–469. DOI: 10.1093/oxfordjournals.aje.a114416.
    1. Belin RJ, Greenland P, Allison M, Martin L, Shikany JM, Larson J, Tinker L, Howard BV, Lloyd‐Jones D, Van Horn L. Diet quality and the risk of cardiovascular disease: the Women's Health Initiative (WHI). Am J Clin Nutr. 2011;94:49–57. DOI: 10.3945/ajcn.110.011221.
    1. Curb JDavid, Mctiernan A, Heckbert SR, Kooperberg C, Stanford J, Nevitt M, Johnson KC, Proulx‐Burns L, Pastore L, Criqui M, et al. Outcomes ascertainment and adjudication methods in the women's health initiative. Ann Epidemiol. 2003;13:S122–128. DOI: 10.1016/S1047-2797(03)00048-6.
    1. van Buuren S . Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res. 2007;16:219–242. DOI: 10.1177/0962280206074463.
    1. Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, Hegele RA, Krauss RM, Raal FJ, Schunkert H, et al. Low‐density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38:2459–2472. DOI: 10.1093/eurheartj/ehx144.
    1. Ference BA, Cannon CP, Landmesser U, Luscher TF, Catapano AL, Ray KK. Reduction of low density lipoprotein‐cholesterol and cardiovascular events with proprotein convertase subtilisin‐kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration. Eur Heart J. 2018;39:2540–2545. DOI: 10.1093/eurheartj/ehx450.
    1. Ras RT, van der Schouw YT , Trautwein EA, Sioen I, Dalmeijer GW, Zock PL, Beulens JW. Intake of phytosterols from natural sources and risk of cardiovascular disease in the European Prospective Investigation into Cancer and Nutrition‐the Netherlands (EPIC‐NL) population. Eur J Prev Cardiol. 2015;22:1067–1075. DOI: 10.1177/2047487314554864.
    1. Chiavaroli L, Viguiliouk E, Nishi S, Blanco Mejia S, Rahelić D, Kahleová H, Salas‐Salvadó J, Kendall C, Sievenpiper J. Dash dietary pattern and cardiometabolic outcomes: an umbrella review of systematic reviews and meta‐analyses. Nutrients. 2019;11:338.
    1. Glenn AJ, Viguiliouk E, Seider M, Boucher BA, Khan TA, Blanco Mejia S, Jenkins DJA, Kahleová H, Rahelić D, Salas‐Salvadó J, et al. Relation of vegetarian dietary patterns with major cardiovascular outcomes: a systematic review and meta‐analysis of prospective cohort studies. Front Nutr. 2019;6:80. DOI: 10.3389/fnut.2019.00080.
    1. Becerra‐Tomas N, Blanco Mejia S, Viguiliouk E, Khan T, Kendall CWC, Kahleova H, Rahelic D, Sievenpiper JL, Salas‐Salvado J. Mediterranean diet, cardiovascular disease and mortality in diabetes: a systematic review and meta‐analysis of prospective cohort studies and randomized clinical trials. Crit Rev Food Sci Nutr. 2020;60:1207–1227. DOI: 10.1080/10408398.2019.1565281.
    1. Lassale C, Gunter MJ, Romaguera D, Peelen LM, Van der Schouw YT, Beulens JWJ, Freisling H, Muller DC, Ferrari P, Huybrechts I, et al. Diet quality scores and prediction of all‐cause, cardiovascular and cancer mortality in a pan‐European cohort study. PLoS One. 2016;11:e0159025. DOI: 10.1371/journal.pone.0159025.
    1. George SM, Ballard‐Barbash R, Manson JE, Reedy J, Shikany JM, Subar AF, Tinker LF, Vitolins M, Neuhouser ML. Comparing indices of diet quality with chronic disease mortality risk in postmenopausal women in the Women's Health Initiative Observational Study: evidence to inform national dietary guidance. Am J Epidemiol. 2014;180:616–625. DOI: 10.1093/aje/kwu173.
    1. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao‐Melacini P, Rangarajan S, Islam S, Pais P, McQueen MJ, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case‐control study. Lancet. 2010;376:112–123. DOI: 10.1016/S0140-6736(10)60834-3.
    1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983–988. DOI: 10.1161/01.STR.22.8.983.
    1. Sranacharoenpong K, Soret S, Harwatt H, Wien M, Sabate J. The environmental cost of protein food choices. Public Health Nutr. 2015;18:2067–2073. DOI: 10.1017/S1368980014002377.
    1. Ritchie H. You want to reduce the carbon footprint of your food? Focus on what you eat, no whether your food is local. 2020.
    1. Fox N, Ward K. Health, ethics and environment: a qualitative study of vegetarian motivations. Appetite. 2008;50:422–429. DOI: 10.1016/j.appet.2007.09.007.
    1. Tilman D, Clark M. Global diets link environmental sustainability and human health. Nature. 2014;515:518–522. DOI: 10.1038/nature13959.
    1. Viguiliouk E, Stewart S, Jayalath V, Ng A, Mirrahimi A, de Souza R , Hanley A, Bazinet R, Blanco Mejia S, Leiter L, et al. Effect of replacing animal protein with plant protein on glycemic control in diabetes: a systematic review and meta‐analysis of randomized controlled trials. Nutrients. 2015;7:9804–9824. DOI: 10.3390/nu7125509.
    1. Mudryj AN, Aukema HM, Yu N. Intake patterns and dietary associations of soya protein consumption in adults and children in the Canadian Community Health Survey, Cycle 2.2. Br J Nutr. 2015;113:299–309. DOI: 10.1017/S0007114514003638.
    1. Klingberg S, Andersson H, Mulligan A, Bhaniani A, Welch A, Bingham S, Khaw KT, Andersson S, Ellegard L. Food sources of plant sterols in the EPIC Norfolk population. Eur J Clin Nutr. 2008;62:695–703. DOI: 10.1038/sj.ejcn.1602765.
    1. Klingberg S, Ellegard L, Johansson I, Hallmans G, Weinehall L, Andersson H, Winkvist A. Inverse relation between dietary intake of naturally occurring plant sterols and serum cholesterol in northern Sweden. Am J Clin Nutr. 2008;87:993–1001. DOI: 10.1093/ajcn/87.4.993.
    1. Jenkins DJA, Kendall CWC, Popovich DG, Vidgen E, Mehling CC, Vuksan V, Ransom TPP, Rao AV, Rosenberg‐Zand R, Tariq N, et al. Effect of a very‐high‐fiber vegetable, fruit, and nut diet on serum lipids and colonic function. Metabolism. 2001;50:494–503. DOI: 10.1053/meta.2001.21037.
    1. Guasch‐Ferre M, Liu G, Li Y, Sampson L, Manson JE, Salas‐Salvado J, Martinez‐Gonzalez MA, Stampfer MJ, Willett WC, Sun Q, et al. Olive oil consumption and cardiovascular risk in U.S. adults. J Am Coll Cardiol. 2020;75:1729–1739.
    1. Schakel SF, Sievert YA, Buzzard IM. Sources of data for developing and maintaining a nutrient database. J Am Diet Assoc. 1988;88:1268–1271.
    1. National Institute for Health and Welfare . Finnish food composition database. 2018.
    1. US Department of Agriculture . USDA national nutrient database for standard reference. 2018.
    1. Jimenez‐Escrig A, Santos‐Hidalgo AB, Saura‐Calixto F. Common sources and estimated intake of plant sterols in the Spanish diet. J Agric Food Chem. 2006;54:3462–3471. DOI: 10.1021/jf053188k.
    1. Normén L, Ellegård L, Brants H, Dutta P, Andersson H. A phytosterol database: fatty foods consumed in Sweden and the Netherlands. J Food Compos Anal. 2007;20:193–201. DOI: 10.1016/j.jfca.2006.06.002.
    1. Normen L, Bryngelsson S, Johnsson M. The phytosterol content of some cereal foods commonly consumed in Sweden and the Netherlands. J Food Compos Anal. 2002;15:693–704.
    1. Phillips KM, Ruggio DM, Ashraf‐Khorassani M. Phytosterol composition of nuts and seeds commonly consumed in the United States. J Agric Food Chem. 2005;53:9436–9445. DOI: 10.1021/jf051505h.
    1. Irwin ML, McTiernan A, Manson JE, Thomson CA, Sternfeld B, Stefanick ML, Wactawski‐Wende J, Craft L, Lane D, Martin LW, et al. Physical activity and survival in postmenopausal women with breast cancer: results from the Women's Health Initiative. Cancer Prev Res (Phila). 2011;4:522–529. DOI: 10.1158/1940-6207.CAPR-10-0295.
    1. Heckbert SR, Kooperberg C, Safford MM, Psaty BM, Hsia J, McTiernan A, Gaziano JM, Frishman WH, Curb JD. Comparison of self‐report, hospital discharge codes, and adjudication of cardiovascular events in the women's health initiative. Am J Epidemiol. 2004;160:1152–1158. DOI: 10.1093/aje/kwh314.
    1. Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ. Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study. Eur Heart J. 2007;28:2937–2943. DOI: 10.1093/eurheartj/ehm400.
    1. Margolis KL, Lihong Q, Brzyski R, Bonds DE, Howard BV, Kempainen S, Simin L, Robinson JG, Safford MM, Tinker LT, et al. Validity of diabetes self‐reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements. Clin Trials. 2008;5:240–247. DOI: 10.1177/1740774508091749.

Source: PubMed

3
Iratkozz fel